AKT1 and rheumatoid arthritis: This, in turn, inhibits the release of inflammatory mediators TNF-α, IL-1β, and IL-6 and suppresses the overactivation of the PI3K/AKT/NF-κB signaling pathway in the synovial membrane of RA rats (Figure 10).